Celldex Therapeutics, Inc. — Director's Dealing 2011

Aug 8, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2011-08-05

Reporting Person: CATLIN AVERY W (Sr. VP & CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-08-05	Incentive Stock Option	$2.80	A	80000	Acquired	2021-08-05	Common Stock (80000)	Direct

Footnotes

F1: 25% vest on August 5, 2012 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.